ONC
Price
$255.86
Change
-$1.14 (-0.44%)
Updated
Jun 6 closing price
Capitalization
29.26B
75 days until earnings call
RGNX
Price
$9.61
Change
+$1.25 (+14.95%)
Updated
Jun 6 closing price
Capitalization
417.84M
52 days until earnings call
Interact to see
Advertisement

ONC vs RGNX

Header iconONC vs RGNX Comparison
Open Charts ONC vs RGNXBanner chart's image
BeOne Medicines
Price$255.86
Change-$1.14 (-0.44%)
Volume$402.22K
Capitalization29.26B
REGENXBIO
Price$9.61
Change+$1.25 (+14.95%)
Volume$1.91M
Capitalization417.84M
ONC vs RGNX Comparison Chart
Loading...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONC vs. RGNX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONC is a Buy and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ONC: $240.41 vs. RGNX: $8.54)
Brand notoriety: ONC and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONC: 40% vs. RGNX: 93%
Market capitalization -- ONC: $29.26B vs. RGNX: $417.84M
ONC [@Biotechnology] is valued at $29.26B. RGNX’s [@Biotechnology] market capitalization is $417.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONC’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • ONC’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ONC and RGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONC’s TA Score shows that 3 TA indicator(s) are bullish while RGNX’s TA Score has 5 bullish TA indicator(s).

  • ONC’s TA Score: 3 bullish, 4 bearish.
  • RGNX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than ONC.

Price Growth

ONC (@Biotechnology) experienced а +1.66% price change this week, while RGNX (@Biotechnology) price change was -11.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ONC is expected to report earnings on Aug 22, 2025.

RGNX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONC($29.3B) has a higher market cap than RGNX($418M). ONC YTD gains are higher at: 30.155 vs. RGNX (10.479). RGNX has higher annual earnings (EBITDA): -198.23M vs. ONC (-396.44M). ONC has more cash in the bank: 2.63B vs. RGNX (235M). RGNX has less debt than ONC: RGNX (82M) vs ONC (1.08B). ONC has higher revenues than RGNX: ONC (3.81B) vs RGNX (83.3M).
ONCRGNXONC / RGNX
Capitalization29.3B418M7,010%
EBITDA-396.44M-198.23M200%
Gain YTD30.15510.479288%
P/E RatioN/AN/A-
Revenue3.81B83.3M4,574%
Total Cash2.63B235M1,118%
Total Debt1.08B82M1,317%
FUNDAMENTALS RATINGS
ONC vs RGNX: Fundamental Ratings
ONC
RGNX
OUTLOOK RATING
1..100
710
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
4853
P/E GROWTH RATING
1..100
10019
SEASONALITY SCORE
1..100
39n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ONC's Valuation (59) in the Biotechnology industry is in the same range as RGNX (74). This means that ONC’s stock grew similarly to RGNX’s over the last 12 months.

ONC's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as RGNX (100). This means that ONC’s stock grew similarly to RGNX’s over the last 12 months.

ONC's SMR Rating (94) in the Biotechnology industry is in the same range as RGNX (98). This means that ONC’s stock grew similarly to RGNX’s over the last 12 months.

ONC's Price Growth Rating (48) in the Biotechnology industry is in the same range as RGNX (53). This means that ONC’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's P/E Growth Rating (19) in the Biotechnology industry is significantly better than the same rating for ONC (100). This means that RGNX’s stock grew significantly faster than ONC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ONCRGNX
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 12 days ago
84%
Momentum
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
81%
MACD
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
76%
Bearish Trend 12 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
80%
Bearish Trend 12 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
76%
Bullish Trend 20 days ago
75%
Declines
ODDS (%)
Bearish Trend 26 days ago
76%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+0.88%
ZLAB - ONC
49%
Loosely correlated
-2.39%
RGNX - ONC
33%
Poorly correlated
-5.84%
AUTL - ONC
32%
Poorly correlated
+5.10%
ROIV - ONC
31%
Poorly correlated
-1.30%
DNLI - ONC
31%
Poorly correlated
-1.29%
More